TCF:

p0.20

+2.56%

TheracryF PLC

GBX as of Aug 3, 2026 | LSE - London Stock Exchange

Company Profile FTSE AIM All-Share

1-Year Price Evolution & Moving Averages

1-Year: -16.67%

Multi-timeframe price chart with technical indicators - Penny sterling (GBX)

Company Description

Company Profile

TheracryF PLC is an innovative player in the pharmaceutical and biotechnology industry. This company specializes in the development and commercialization of cutting-edge therapeutic solutions. Focused on addressing unmet medical needs, TheracryF PLC invests heavily in research and development to bring new drugs and treatments to market. The company's portfolio includes a range of products targeting various critical health conditions, enhancing patient care and improving life quality. By partnering with healthcare providers, research institutions, and regulatory bodies, TheracryF PLC ensures the safe and efficient deployment of its pharmaceutical products. As a pivotal entity in the biotech sector, TheracryF PLC contributes significantly to healthcare advancements, fostering medical innovation and supporting public health initiatives worldwide. Its strategic initiatives and rigorous approach to product development underscore its relevance and impact within the global financial markets, making it a key entity to watch in the ever-evolving landscape of healthcare solutions.

United Kingdom Healthcare Biotechnology UK Healthcare UK Biotechnology

Risk & Valuation

as of Jul. 21, 2026

Beta	1.41
Trailing PE	-58.33
Forward PE	-1.73

Stock Data

Open	p0.20
High	p0.21
Low	p0.19
Close	p0.20
Volume	2,130,495
Previous Close	p0.20
1-Day Change	+0.01
1-Year Change	-0.04
Average Daily Volume	4,177,669
52-Week High	p0.26
52-Week Low	p0.19

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.